Factors influencing insulin usage among type 2 diabetes mellitus patients: A study in Turkish primary care

dc.contributor.authorYilmaz, Ahmet
dc.contributor.authorAk, Muharrem
dc.contributor.authorCim, Abdullah
dc.contributor.authorPalanci, Yilmaz
dc.contributor.authorKilinc, Faruk
dc.date.accessioned2024-04-24T17:07:46Z
dc.date.available2024-04-24T17:07:46Z
dc.date.issued2016
dc.departmentDicle Üniversitesien_US
dc.description.abstractBackground: DM (diabetes mellitus) patients with poorly regulated blood glucose levels are at risk of increased morbidity and mortality. There are different factors that cause resistance to the initiation of insulin therapy such as beliefs and perceptions concerning diabetes and its treatment and the nature and consequences of insulin therapy. Objectives: We aimed to explore the reasons for this reluctance and how these obstacles could be overcome so that DM patients who require insulin could initiate therapy. Methods: This was a cross-sectional, descriptive study of diabetic patients with glycated haemoglobin A(1c) (HbA(1C)) levels above 7.0%, who were followed-up at a primary care and endocrinology outpatient clinic. Results: Ninety-four patients (57.4% females, 42.6% males) were recruited for this study. Most patients (57.4%) considered that insulin was a drug of last resort. Among all patients, 34.1% thought that insulin lowered blood glucose levels to an extreme degree and 14.9% disagreed. The patients thought that self-injection was hard (27.6%), required someone else to administer the injection (27.6%), insulin injection was painful (33.0%). 59.6% of all patients believed that their religion did not restrict the use of insulin, 52.1% stated that their family physicians had sufficiently informed them. Conclusion: Our most significant finding is that a lack of adequate information relating to insulin appears to be the major factor behind DM patients' refusal of insulin treatment. The fact that patients consider insulin treatment as a final solution to DM could be related to resistance to the initiation of insulin therapy.en_US
dc.identifier.doi10.1080/13814788.2016.1230603
dc.identifier.endpage261en_US
dc.identifier.issn1381-4788
dc.identifier.issn1751-1402
dc.identifier.issue4en_US
dc.identifier.pmid27652800
dc.identifier.scopus2-s2.0-84988662343
dc.identifier.scopusqualityQ1
dc.identifier.startpage255en_US
dc.identifier.urihttps://doi.org/10.1080/13814788.2016.1230603
dc.identifier.urihttps://hdl.handle.net/11468/16972
dc.identifier.volume22en_US
dc.identifier.wosWOS:000392620500008
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherTaylor & Francis Ltden_US
dc.relation.ispartofEuropean Journal of General Practice
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectFamily Physicianen_US
dc.subjectEducational Statusen_US
dc.subjectInsulin Resistanceen_US
dc.subjectReligionen_US
dc.titleFactors influencing insulin usage among type 2 diabetes mellitus patients: A study in Turkish primary careen_US
dc.titleFactors influencing insulin usage among type 2 diabetes mellitus patients: A study in Turkish primary care
dc.typeArticleen_US

Dosyalar